Search

everythinglearnresearchcommunity

for

Search:↓

Women with polycystic ovary syndrome tend to have a longer anogenital distance.

Brazilian women with PCOS and both menstrual irregularity and high male hormone levels have a higher chance of having metabolic syndrome.

Insulin-sensitizing drugs like metformin can help with ovulation, weight loss, and lower testosterone in some women with PCOS.

Hormonal treatments are effective as a second-line option for moderate-to-severe acne in females, but should be used with caution due to health risks.

The study suggests that being overweight or obese, not PCOS itself, is strongly linked to insulin resistance.

New treatments for PCOS focus on insulin resistance and reducing testosterone levels, along with traditional hormone therapies.

The study concluded that both anti-Mullerian hormone and LH/FSH ratio are higher in women with PCOS and combining these markers with BMI could improve diagnosis accuracy.

The research found different metabolism changes in PCOS patients and suggested new potential markers for diagnosing PCOS with or without insulin resistance.

Acne is common in women, often hormone-related, negatively affects quality of life, and requires various treatments.

The document concludes that new treatments are needed to better manage acne and reduce side effects related to current therapies.

South Asian women with PCOS present with different symptoms compared to White women, influenced by ethnicity, obesity, and age.

Ovarian SAHA syndrome makes women with PCOS more resistant to insulin and increases their risk of blood sugar problems.

Caucasian and Asian women with PCOS generally show similar symptoms, except Asian women have less chest hair.

Women with PCOS who had antiandrogenic treatment before pregnancy had fewer complications than those without treatment.

Certain skin conditions can indicate insulin resistance and should prompt lifestyle changes and medical treatment to manage underlying health issues.

Daughters of women with PCOS generally experience normal puberty but may have more body hair and different body fat distribution.

PCOS is a complex disorder managed by treating symptoms and requires a team of specialists.

Finasteride cream reduces hair growth in women with hirsutism, but more research needed.

Women with PCOS have higher xanthine oxidase activity linked to inflammation and heart disease risks.

High levels of TNF-α may contribute to obesity and insulin resistance in PCOS, but not due to the C850T genetic variation.

Hormonal changes after childbirth and menopause can lead to women's hair loss and facial hair growth, with a need for better treatments.

Diagnosing PCOS in teenagers should focus on signs of excess male hormones and not rely solely on ovarian ultrasound or irregular periods, and should be reassessed in adulthood.

Birth control pills combined with bicalutamide are more effective at reducing excessive hair growth in women with PCOS than birth control pills alone.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

Researchers found potential urine markers for polycystic ovary syndrome, including testosterone-glucuronide and 11α-hydroxyprogesterone, which may help diagnose the condition.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

An mFG score of 7 or higher indicates hirsutism in Filipino women, often linked to higher free testosterone levels.

More adolescent girls in urban areas of India have Polycystic Ovary Syndrome compared to those in rural areas.

Family members of North Indian women with PCOS have a high rate of metabolic syndrome.

Finasteride reduces dihydrotestosterone, increases testosterone, and may treat hirsutism in women.